Literature DB >> 19683657

Essential criteria for evaluation of pneumococcal conjugate vaccine candidates.

Peter Paradiso1.   

Abstract

In 2003, the World Health Organization recommended a concentration of enzyme-linked immunosorbent assay (ELISA) immunoglobulin G (IgG) anti-capsular antibody of 0.35 microg/mL as a reference value that correlates to protection against invasive pneumococcal disease. This threshold can be used to demonstrate immunologic non-inferiority of a new vaccine in comparison trials that use pneumococcal conjugate vaccines (PCVs) as a comparator. An investigational 13-valent PCV (PCV13) compared with seven-valent PCV (PCV7) demonstrated that all of the pneumococcal serotypes contained in PCV13 were immunogenic, with 88-98% of vaccinees achieving antibody concentration > or = 0.35 microg/mL for serotypes shared with PCV7 and >96% for six additional serotypes.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19683657     DOI： 10.1016/j.vaccine.2009.06.008

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


  11 in total

Review 1.  Correlates of protection induced by vaccination.

Authors:  Stanley A Plotkin
Journal:  Clin Vaccine Immunol       Date:  2010-05-12

2.  Pneumococcal glycoconjugate vaccines produce antibody responses that strongly correlate with function.

Authors:  Paul V Licciardi; Anne Balloch; Fiona M Russell; Moon H Nahm; Kim Mulholland; Mimi L K Tang
Journal:  Nat Rev Drug Discov       Date:  2011-05       Impact factor: 84.694

3.  Update on the Use of Conjugate Pneumococcal Vaccines in Childhood: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)†.

Authors:  Shalini Desai; Allison McGeer; Caroline Quach-Thanh; Denise Elliott
Journal:  Can Commun Dis Rep       Date:  2010-11-23

4.  RrgB321, a fusion protein of the three variants of the pneumococcal pilus backbone RrgB, is protective in vivo and elicits opsonic antibodies.

Authors:  Carole Harfouche; Sara Filippini; Claudia Gianfaldoni; Paolo Ruggiero; Monica Moschioni; Silvia Maccari; Laura Pancotto; Letizia Arcidiacono; Bruno Galletti; Stefano Censini; Elena Mori; Marzia Giuliani; Claudia Facciotti; Elena Cartocci; Silvana Savino; Francesco Doro; Michele Pallaoro; Salvatore Nocadello; Giuseppe Mancuso; Mitch Haston; David Goldblatt; Michèle A Barocchi; Mariagrazia Pizza; Rino Rappuoli; Vega Masignani
Journal:  Infect Immun       Date:  2011-11-14       Impact factor: 3.441

5.  Immunogenicity of a live recombinant Salmonella enterica serovar typhimurium vaccine expressing pspA in neonates and infant mice born from naive and immunized mothers.

Authors:  Huoying Shi; Shifeng Wang; Kenneth L Roland; Bronwyn M Gunn; Roy Curtiss
Journal:  Clin Vaccine Immunol       Date:  2010-01-06

6.  Combining viral vectored and protein-in-adjuvant vaccines against the blood-stage malaria antigen AMA1: report on a phase 1a clinical trial.

Authors:  Susanne H Hodgson; Prateek Choudhary; Sean C Elias; Kathryn H Milne; Thomas W Rampling; Sumi Biswas; Ian D Poulton; Kazutoyo Miura; Alexander D Douglas; Daniel Gw Alanine; Joseph J Illingworth; Simone C de Cassan; Daming Zhu; Alfredo Nicosia; Carole A Long; Sarah Moyle; Eleanor Berrie; Alison M Lawrie; Yimin Wu; Ruth D Ellis; Adrian V S Hill; Simon J Draper
Journal:  Mol Ther       Date:  2014-08-26       Impact factor: 11.454

Review 7.  The RH5-CyRPA-Ripr Complex as a Malaria Vaccine Target.

Authors:  Robert J Ragotte; Matthew K Higgins; Simon J Draper
Journal:  Trends Parasitol       Date:  2020-04-28

Review 8.  Utilizing poxviral vectored vaccines for antibody induction-progress and prospects.

Authors:  Simon J Draper; Matthew G Cottingham; Sarah C Gilbert
Journal:  Vaccine       Date:  2013-06-05       Impact factor: 3.641

9.  Evaluation of a Validated Luminex-Based Multiplex Immunoassay for Measuring Immunoglobulin G Antibodies in Serum to Pneumococcal Capsular Polysaccharides.

Authors:  Charles Y Tan; Fred W Immermann; Shite Sebastian; Michael W Pride; Danka Pavliakova; Kelly A Belanger; Wendy Watson; Daniel A Scott; Mohinder Sidhu; Kathrin U Jansen; Peter C Giardina
Journal:  mSphere       Date:  2018-08-08       Impact factor: 4.389

10.  Development and Validation of 13-plex Luminex-Based Assay for Measuring Human Serum Antibodies to Streptococcus pneumoniae Capsular Polysaccharides.

Authors:  Danka Pavliakova; Peter C Giardina; Soraya Moghazeh; Shite Sebastian; Maya Koster; Viliam Pavliak; Andrew McKeen; Roger French; Kathrin U Jansen; Michael Pride
Journal:  mSphere       Date:  2018-08-08       Impact factor: 4.389
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.